RBM Partnership to End Malaria welcomes WHO’s recommendation of world’s second malaria vaccine

Global malaria community calls for increased investment in development and scale-up of malaria innovations following R21 vaccine announcement – but RBM Partnership warns “it’s not the only solution”.

New data highlights rebound in routine immunisation underpinned by record domestic funding; warns of challenges ahead

Basic childhood immunisation rebounded in 2022, as lower-income countries committed historic levels of domestic funding to immunisation programmes.

New funding boosts efforts to vaccinate “zero-dose” children in the Democratic Republic of the Congo

Efforts to vaccinate “zero-dose” children in the Democratic Republic of the Congo (DRC) will be accelerated thanks to new funding from Gavi, the Vaccine Alliance’s Equity Accelerator Fund (EAF).

MEDIA FACTSHEET: Takeaways from the 2022 WUENIC estimates for 57 lower-income countries supported by Gavi

Lower-income countries supported by the Alliance are on the road to recovery, with DTP3 vaccine coverage going up by 3 percentage points.

Global Fund, Gavi and AFROSAI-E Come Together to Strengthen Supreme Audit Institutions in Member African Countries

Through a memorandum of understanding (MoU), the three organizations will work together to coordinate and facilitate the exchange of information, experience and knowledge concerning audit and advisory activities.

18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023–2025: Gavi, WHO and UNICEF

Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years.

Global Vaccine Alliance to deploy six-in-one vaccine to lower-income countries, establish innovative mechanisms to protect against future epidemic threats

Gavi’s Board approved new investments in six-in-one (hexavalent) vaccine and approved a long list of potential new vaccines for consideration for inclusion in future Gavi programmes at its Board Meeting, which concluded today 

David Marlow to Become Interim Chief Executive Officer of Gavi

The Gavi Board decided today to appoint David Marlow, currently Gavi`s Chief Operating Officer, to the position of Interim Chief Executive Officer, effective 3 August 2023.

Madrid conference marks reaching over 1 billion children vaccinated, reviews progress and resolves to tackle challenges

The Global Vaccine Impact Conference closed today, as the Vaccine Alliance marked more than 1 billion children vaccinated through its programmes.

Vaccine Alliance reaches more than one billion children

Gavi, the Vaccine Alliance, has now facilitated the immunisation of more than one billion children with childhood vaccines.

Spanish Government brings global leaders together to take stock of the state of global vaccination, discuss its future

Global leaders and immunisation experts are coming together to assess the progress of the Vaccine Alliance and discuss the challenges it faces in the future.

Global vaccine alliance outlines path to sustainable cholera vaccine supply

Global oral cholera vaccine (OCV) supply could enable large-scale preventive vaccination by 2026 – but urgent action is needed to achieve this goal.

Last updated: 25 Feb 2021

Subscribe to our newsletter